Functional Crosstalk between CB and TRPV1 Receptors Protects Nigrostriatal Dopaminergic Neurons in the MPTP Model of Parkinson’s Disease

Functional Crosstalk between CB and TRPV1 Receptors Protects Nigrostriatal Dopaminergic Neurons in the MPTP Model of Parkinson’s Disease

The present study examined whether crosstalk between cannabinoid (CB) and transient potential receptor vanilloid type 1 (TRPV1) could contribute to the survival of nigrostriatal dopamine neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson’s disease (PD). MPTP...

Full description

Bibliographic Details
Main Authors:	Rayul Wi, Young Cheul Chung, Byung Kwan Jin
Format:	Article
Language:	English
Published:	Hindawi Limited 2020-01-01
Series:	Journal of Immunology Research
Online Access:	http://dx.doi.org/10.1155/2020/5093493

Similar Items

MMP-3 Contributes to Nigrostriatal Dopaminergic Neuronal Loss, BBB Damage, and Neuroinflammation in an MPTP Mouse Model of Parkinson’s Disease
by: Young Cheul Chung, et al.
Published: (2013-01-01)

Hydralazine Protects Nigrostriatal Dopaminergic Neurons From MPP+ and MPTP Induced Neurotoxicity: Roles of Nrf2-ARE Signaling Pathway
by: Xingfang Guo, et al.
Published: (2019-03-01)

Iron Chelators and Antioxidants Regenerate Neuritic Tree and Nigrostriatal Fibers of MPP+/MPTP-Lesioned Dopaminergic Neurons.
by: Pabla Aguirre, et al.
Published: (2015-01-01)

Intermittent hypoxia prevents MPTP-induced neurotoxicity in nigrostriatal dopaminergic system in mice
by: Jin-Hey Lai, et al.
Published: (2000)

Comparison of the phsiology and vulnerability of the nigrostriatal and mesolimbic dopaminergic pathways upon MPTP/MPP+ administration
by: Hong, Hui Juan, et al.
Published: (1996)

Smilagenin Protects Dopaminergic Neurons in Chronic MPTP/Probenecid—Lesioned Parkinson’s Disease Models
by: Xuan He, et al.
Published: (2019-02-01)

Dynamic Changes in the Nigrostriatal Pathway in the MPTP Mouse Model of Parkinson’s Disease
by: Dongping Huang, et al.
Published: (2017-01-01)

Clinical Features Indicating Nigrostriatal Dopaminergic Degeneration in Drug-Induced Parkinsonism
by: Seung Ha Lee, et al.
Published: (2017-01-01)

MPTP-induced glial activation in the mice nigrostriatal pathway
by: Pei-Chi Hsu, et al.
Published: (2002)

TRH Analog, Taltirelin Protects Dopaminergic Neurons From Neurotoxicity of MPTP and Rotenone
by: Cong Zheng, et al.
Published: (2018-12-01)

7,8-Dihydroxyflavone Protects Nigrostriatal Dopaminergic Neurons from Rotenone-Induced Neurotoxicity in Rodents
by: Shuke Nie, et al.
Published: (2019-01-01)

Function and Regulation of ALDH1A1-Positive Nigrostriatal Dopaminergic Neurons in Motor Control and Parkinson’s Disease
by: Kathleen Carmichael, et al.
Published: (2021-05-01)

Activation of tyrosine kinase receptor signaling pathway by rasagiline facilitates neurorescue and restoration of nigrostriatal dopamine neurons in post-MPTP-induced parkinsonism
by: Yotam Sagi, et al.
Published: (2007-01-01)

CDNF Protects the Nigrostriatal Dopamine System and Promotes Recovery after MPTP Treatment in Mice
by: Mikko Airavaara, et al.
Published: (2012-06-01)

Vitexin protects dopaminergic neurons in MPTP-induced Parkinson’s disease through PI3K/Akt signaling pathway
by: Hu M, et al.
Published: (2018-03-01)

Interleukin-4 Protects Dopaminergic Neurons In vitro but Is Dispensable for MPTP-Induced Neurodegeneration In vivo
by: Laura Hühner, et al.
Published: (2017-03-01)

Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in mice
by: Wang Qingshan, et al.
Published: (2012-06-01)

Atrazine Causes Autophagy- and Apoptosis-Related Neurodegenerative Effects in Dopaminergic Neurons in the Rat Nigrostriatal Dopaminergic System
by: Xiao-Yao Song, et al.
Published: (2015-06-01)

Urinary Dysfunction Is Associated with Nigrostriatal Dopaminergic Degeneration in Early and Untreated Patients with Parkinson’s Disease
by: Jing Wang, et al.
Published: (2020-01-01)

Increased expression of Kv2.1 channel contributes to nigrostriatal degeneration in the MPTP mouse model of Parkinson’s disease
by: Ru-YiChao, et al.
Published: (2017)

Batryticatus Bombyx Protects Dopaminergic Neurons Against MPTP-Induced Neurotoxicity by Inhibiting Oxidative Damage
by: Hye-Sun Lim, et al.
Published: (2019-11-01)

miR‐30b protects nigrostriatal dopaminergic neurons from MPP(+)‐induced neurotoxicity via SNCA
by: Yu‐fei Shen, et al.
Published: (2020-04-01)

Cooperative synthesis of dopamine by non-dopaminergic neurons as a compensatory mechanism in the striatum of mice with MPTP-induced Parkinsonism
by: Elena A. Kozina, et al.
Published: (2017-02-01)

Lack of CCR5 modifies glial phenotypes and population of the nigral dopaminergic neurons, but not MPTP-induced dopaminergic neurodegeneration
by: Dong-Young Choi, et al.
Published: (2013-01-01)

Inhibition of the hepatic Nlrp3 protects dopaminergic neurons via attenuating systemic inflammation in a MPTP/p mouse model of Parkinson’s disease
by: Chen Qiao, et al.
Published: (2018-07-01)

Inter-hemispheric asymmetry of nigrostriatal dopaminergic lesion. A possible compensatory mechanism in Parkinson’s disease
by: Javier eBlesa, et al.
Published: (2011-11-01)

Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson’s Disease Induced by MPTP
by: Juan M. Viveros-Paredes, et al.
Published: (2017-07-01)

Interleukin-13 Propagates Prothrombin Kringle-2-Induced Neurotoxicity in Hippocampi In Vivo via Oxidative Stress
by: Jae Yeong Jeong, et al.
Published: (2021-03-01)

Neuroelectrophysiological Evaluation of the Sensorimotor System in Dopaminergic Nigrostriatal Dysfunction
by: Shiang-Jiun Chen, et al.
Published: (2001)

Sex Differences of Neurotransporters Within the Nigrostriatal Dopaminergic System
by: Ji, Jing
Published: (2008)

Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: Diminished compensatory mechanisms as a prelude to parkinsonism
by: Timothy J. Collier, et al.
Published: (2007-04-01)

Neonatal exposure to lipopolysaccharide enhances vulnerability of nigrostriatal dopaminergic neurons to rotenone neurotoxicity in later life
by: Lir-Wan Fan, et al.
Published: (2011-12-01)

Lesion of the subthalamic nucleus reverses motor deficits but not death of nigrostriatal dopaminergic neurons in a rat 6-hydroxydopamine-lesion model of Parkinson's disease
by: V. Rizelio, et al.
Published: (2010-01-01)

Protective effects of a polysaccharide from Spirulina platensis on dopaminergic neurons in an MPTP-induced Parkinson′s disease model in C57BL/6J mice
by: Fang Zhang, et al.
Published: (2015-01-01)

Gastrodin Protects Apoptotic Dopaminergic Neurons in a Toxin-Induced Parkinson’s Disease Model
by: Hemant Kumar, et al.
Published: (2013-01-01)

Pathological remodelling of colonic wall following dopaminergic nigrostriatal neurodegeneration
by: Carolina Pellegrini, et al.
Published: (2020-06-01)

Selective destruction of nigrostriatal dopaminergic neurons does not alter [3H]-ryanodine binding in rat striatum
by: F. Noël, et al.
Published: (2000-02-01)

Nigrostriatal Dopaminergic Denervation Does Not Promote Impulsive Choice in the Rat: Implication for Impulse Control Disorders in Parkinson’s Disease
by: Robin Magnard, et al.
Published: (2018-12-01)

GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson’s disease
by: Xavier ed'Anglemont De Tassigny, et al.
Published: (2015-02-01)

Peripheral Inflammation Increases the Damage in Animal Models of Nigrostriatal Dopaminergic Neurodegeneration: Possible Implication in Parkinson's Disease Incidence
by: A. Machado, et al.
Published: (2011-01-01)